The Nano-Concepts 2 Stage antimicrobial system consists of a hospital/institutional grade disinfectant and a durable, long lasting antimicrobial surface coating. The disinfectant is included in the CDC list of recommended formulations.
On August 1, 2014, CDC released guidance titled,”Infection Prevention and Control Recommendations for Hospitalized Patients with Known or Suspected Ebola Hemorrhagic Fever in U.S. Hospitals.”
Frequently Asked Questions
1. How can I determine whether a particular EPA-registered hospital disinfectant is appropriate for use in the room of a patient with suspected or confirmed Ebola virus infection?
Check EPA’s Disinfectants for Use Against the Ebola Virus for a list of EPA-registered disinfectants. Users should be aware that an ‘enveloped’ or ‘non-enveloped virus’ designation may not be included on the container label. Instead check the disinfectant’s label for at least one of the common non-enveloped viruses (e.g., norovirus, rotavirus, adenovirus, poliovirus).
2. Are there special instructions for cleaning and disinfecting the room of a patient with suspected or confirmed Ebola virus infection?
Daily cleaning and disinfection of hard, non-porous surfaces (e.g., high-touch surfaces such as bed rails and over bed tables, housekeeping surfaces such as floors and counters) should be done.4 Before disinfecting a surface, cleaning should be performed. In contrast to disinfection where products with specific claims are used, any cleaning product can be used for cleaning tasks. Use cleaning and disinfecting products according to label instructions. Check the disinfectant’s label for specific instructions for inactivation of any of the non-enveloped viruses (e.g., norovirus, rotavirus, adenovirus, poliovirus) follow label instructions for use of the product that are specific for inactivation of that virus. Use disposable cleaning cloths, mop cloths, and wipes and dispose of these in leak-proof bags. Use a rigid waste receptacle designed to support the bag to help minimize contamination of the bag’s exterior.
3. How should spills of blood or other body substances be managed?
The basic principles for blood or body substance spill management are outlined in the United States Occupational Safety and Health Administration (OSHA) Bloodborne Pathogen Standards (29 CFR 1910.1030).5 CDC guidelines recommend removal of bulk spill matter, cleaning the site, and then disinfecting the site.4 For large spills, a chemical disinfectant with sufficient potency is needed to overcome the tendency of proteins in blood and other body substances to neutralize the disinfectant’s active ingredient. An EPA-registered hospital disinfectant with label claims for non-enveloped viruses (e.g., norovirus, rotavirus, adenovirus, poliovirus) and instructions for cleaning and decontaminating surfaces or objects soiled with blood or body fluids should be used according to those instructions.
Disinfectants for Use Against the Ebola Virus
This list of registered disinfectants meets the Center for Disease Control’s (CDC) criteria for use against the Ebola virus on hard, non-porous surfaces. It is necessary to follow the specific use instructions on the label for each disinfectant in order for the disinfectant to be effective. The product label will not specifically mention effectiveness against the Ebola virus. Instead, it will mention effectiveness against a different virus, such as norovirus, rotavirus, adenovirus, and/or poliovirus.
CDC’s guidance recommends:
- The use of an EPA-registered hospital disinfectant with a label claim for use against a non-enveloped virus (e.g., norovirus, rotavirus, adenovirus, poliovirus); and
- The product label use directions for the non-enveloped virus or viruses should be followed when disinfecting against the Ebola virus.
Note: The list below is not a comprehensive list. There may be additional disinfectants that meet the CDC’s Interim Guidance for Environmental Infection Control in Hospitals for Ebola Virus and EPA will update this list with additional products as needed.